Programming megakaryocytes to produce engineered platelets for delivering non-native proteins

Platelets are anucleate cells naturally filled with secretory granules that store large amounts of protein to be released in response to certain physiological conditions. Cell engineering can endow platelets with the ability to deliver non-native proteins by modifying them as they develop during the cell fate process. This study presents a strategy to efficiently generate mouse platelets from pluripotent stem cells and demonstrates their potential as bioengineered protein delivery platforms. By modifying megakaryocytes, the progenitor cells of platelets, we successfully engineered platelets capable of packaging and delivering non-native proteins. These engineered platelets can offer flexible delivery platforms to release non-native proteins in a controlled manner upon activation when packaged into α-granules or deliver active enzymes to genetically alter recipient cells. Our findings highlight platelets as a promising tool for protein delivery in cell therapy applications.

Authors

Institutions

Publication Details

Journal
Communications Biology
Published
2025-04-19
DOI
https://doi.org/10.1038/s42003-025-08017-8
Citations
2
Primary Topic
Platelet Disorders and Treatments
Type
article
Field-Weighted Citation Impact
3.54

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Programming megakaryocytes to produce engineered platelets for delivering non-native proteins

James D. Craig, Tara L. Deans, Mitchell R. Lewis, Shwan B. Javdan et al.
2 citations
Communications Biology
Platelet Disorders and Treatments
3.54
article

Programming megakaryocytes to produce engineered platelets for delivering non-native proteins

James D. Craig, Tara L. Deans, Mitchell R. Lewis, Shwan B. Javdan, Farhana Islam, Han Wu
article en
2 citations

Abstract

Platelets are anucleate cells naturally filled with secretory granules that store large amounts of protein to be released in response to certain physiological conditions. Cell engineering can endow platelets with the ability to deliver non-native proteins by modifying them as they develop during the cell fate process. This study presents a strategy to efficiently generate mouse platelets from pluripotent stem cells and demonstrates their potential as bioengineered protein delivery platforms. By modifying megakaryocytes, the progenitor cells of platelets, we successfully engineered platelets capable of packaging and delivering non-native proteins. These engineered platelets can offer flexible delivery platforms to release non-native proteins in a controlled manner upon activation when packaged into α-granules or deliver active enzymes to genetically alter recipient cells. Our findings highlight platelets as a promising tool for protein delivery in cell therapy applications.

Communications BiologyVol. 8(1)
Georgia Institute of Technology (US), University of Utah (US), The Wallace H. Coulter Department of Biomedical Engineering (US)
University of Utah, National Institutes of Health, National Cancer Institute
Zero hunger
Openalex Percentile: Top 8%
Platelet Disorders and Treatments
3.54
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Programming megakaryocytes to produce engineered platelets for delivering non-native proteins — James D. Craig, Tara L. Deans, et al. · Communications Biology (2025) | TGRS Research Map | TGRS